Study design

JB Johanna K. Björk
IA Ilmari Ahonen
TM Tuomas Mirtti
AE Andrew Erickson
AR Antti Rannikko
AB Anna Bützow
SN Stig Nordling
JL Johan Lundin
ML Mikael Lundin
LS Lea Sistonen
MN Matthias Nees
Malin Åkerfelt
request Request a Protocol
ask Ask a question
Favorite

Reporting recommendations for tumor marker prognostic studies; REMARK [45] was followed throughout the study. The study design is outlined in Supplementary Figure 5.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A